Literature DB >> 33611546

Susceptibility to ischaemic heart disease: Focusing on genetic variants for ATP-sensitive potassium channel beyond traditional risk factors.

Paolo Severino1, Andrea D'Amato1, Lucrezia Netti1, Mariateresa Pucci1, Marco V Mariani1, Sara Cimino1, Lucia I Birtolo1, Fabio Infusino1, Paolo De Orchi1, Raffaele Palmirotta2, Domenica Lovero2, Franco Silvestris2, Viviana Caputo3, Antonio Pizzuti3, Fabio Miraldi1, Viviana Maestrini1, Massimo Mancone1, Francesco Fedele1.   

Abstract

AIMS: Ischaemic heart disease is classically associated with coronary artery disease. Recent evidences showed the correlation between coronary microvascular dysfunction and ischaemic heart disease, even independently of coronary artery disease. Ion channels represent the final effectors of blood flow regulation mechanisms and their genetic variants, in particular of Kir6.2 subunit of the ATP-sensitive potassium channel (KATP), are reported to be involved in ischaemic heart disease susceptibility. The aim of the present study is to evaluate the role of KATP channel and its genetic variants in patients with ischaemic heart disease and evaluate whether differences exist between coronary artery disease and coronary microvascular dysfunction.
METHODS: A total of 603 consecutive patients with indication for coronary angiography due to suspected myocardial ischaemia were enrolled. Patients were divided into three groups: coronary artery disease (G1), coronary microvascular dysfunction (G2) and normal coronary arteries (G3). Analysis of four single nucleotide polymorphisms (rs5215, rs5216, rs5218 and rs5219) of the KCNJ11 gene encoding for Kir6.2 subunit of the KATP channel was performed.
RESULTS: rs5215 A/A and G/A were significantly more represented in G1, while rs5215 G/G was significantly more represented in G3, rs5216 G/G and C/C were both more represented in G3, rs5218 C/C was more represented in G1 and rs5219 G/A was more represented in G1, while rs5219 G/G was significantly more represented in G2. At multivariate analysis, single nucleotide polymorphism rs5215_G/G seems to represent an ischaemic heart disease independent protective factor.
CONCLUSIONS: These results suggest the potential role of KATP genetic variants in ischaemic heart disease susceptibility, as an independent protective factor. They may lead to a future perspective for gene therapy against ischaemic heart disease. © The European Society of Cardiology 2020.

Entities:  

Keywords:  ATP-sensitive potassium channel; Ion channels; coronary artery disease; coronary microvascular dysfunction; ischaemic heart disease; single nucleotide polymorphisms

Year:  2020        PMID: 33611546     DOI: 10.1177/2047487320926780

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  11 in total

1.  Agreement of Angiography-Derived and Wire-Based Fractional Flow Reserves in Percutaneous Coronary Intervention.

Authors:  Hu Ai; Naixin Zheng; Le Li; Guojian Yang; Hui Li; Guodong Tang; Qi Zhou; Huiping Zhang; Xue Yu; Feng Xu; Ying Zhao; Fucheng Sun
Journal:  Front Cardiovasc Med       Date:  2021-04-23

2.  Bioinformatics Analysis Reveals Diagnostic Markers and Vital Pathways Involved in Acute Coronary Syndrome.

Authors:  Mingshuang Li; Conglin Ren; Chenxia Wu; Xinyao Li; Xinyi Li; Wei Mao
Journal:  Cardiol Res Pract       Date:  2020-11-06       Impact factor: 1.990

Review 3.  Ischemic Heart Disease Pathophysiology Paradigms Overview: From Plaque Activation to Microvascular Dysfunction.

Authors:  Paolo Severino; Andrea D'Amato; Mariateresa Pucci; Fabio Infusino; Francesco Adamo; Lucia Ilaria Birtolo; Lucrezia Netti; Giulio Montefusco; Cristina Chimenti; Carlo Lavalle; Viviana Maestrini; Massimo Mancone; William M Chilian; Francesco Fedele
Journal:  Int J Mol Sci       Date:  2020-10-30       Impact factor: 6.208

4.  Impact of Platelet Glycoprotein Ia/IIa C807T Gene Polymorphisms on Coronary Artery Aneurysms of KD Patients.

Authors:  Wei Li; Lei Pi; Jia Yuan; Xueping Gu; Zhouping Wang; Yunfeng Liu; Qiulian Deng; Yanfei Wang; Ping Huang; Li Zhang; Xiaoqiong Gu
Journal:  Cardiol Res Pract       Date:  2021-02-23       Impact factor: 1.990

5.  Detection of Coronary Artery Disease by an Erectile Dysfunction Questionnaire.

Authors:  Mehrab Sayadi; Reza Elmafshar; Iman Razeghian-Jahromi; Mohammad Javad Zibaeenezhad
Journal:  Cardiol Res Pract       Date:  2021-03-13       Impact factor: 1.990

6.  Low-Density Lipoprotein Cholesterol Levels in Coronary Artery Disease Patients: Opportunities for Improvement.

Authors:  Gary J Martin; Meron Teklu; Edwin Mandieka; Joe Feinglass
Journal:  Cardiol Res Pract       Date:  2022-04-27       Impact factor: 1.990

7.  Automatic Segmentation and Cardiac Mechanics Analysis of Evolving Zebrafish Using Deep Learning.

Authors:  Bohan Zhang; Kristofor E Pas; Toluwani Ijaseun; Hung Cao; Peng Fei; Juhyun Lee
Journal:  Front Cardiovasc Med       Date:  2021-06-09

Review 8.  Approaching Sex Differences in Cardiovascular Non-Coding RNA Research.

Authors:  Amela Jusic; Antonio Salgado-Somoza; Ana B Paes; Francesca Maria Stefanizzi; Núria Martínez-Alarcón; Florence Pinet; Fabio Martelli; Yvan Devaux; Emma Louise Robinson; Susana Novella
Journal:  Int J Mol Sci       Date:  2020-07-10       Impact factor: 6.208

9.  Impact of Renal Function on Long-Term Clinical Outcomes in Patients With Coronary Chronic Total Occlusions: Results From an Observational Single-Center Cohort Study During the Last 12 Years.

Authors:  Lei Guo; Huaiyu Ding; Haichen Lv; Xiaoyan Zhang; Lei Zhong; Jian Wu; Jiaying Xu; Xuchen Zhou; Rongchong Huang
Journal:  Front Cardiovasc Med       Date:  2020-11-16

Review 10.  Myocardial Tissue Characterization in Heart Failure with Preserved Ejection Fraction: From Histopathology and Cardiac Magnetic Resonance Findings to Therapeutic Targets.

Authors:  Paolo Severino; Andrea D'Amato; Silvia Prosperi; Francesca Fanisio; Lucia Ilaria Birtolo; Bettina Costi; Lucrezia Netti; Cristina Chimenti; Carlo Lavalle; Viviana Maestrini; Massimo Mancone; Francesco Fedele
Journal:  Int J Mol Sci       Date:  2021-07-17       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.